IP Verse

Stable Pharmaceutical Composition For Oral Administration

Patent No. EP3318259 (titled "Stable Pharmaceutical Composition For Oral Administration") was filed by Astellas Pharma on Jul 1, 2016. The application was issued on Jan 11, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKOct 11, 2023ELKINGTON AND FIFE
SANDOZOct 10, 2023KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3318259

ASTELLAS PHARMA
Application Number
EP16821324A
Filing Date
Jul 1, 2016
Status
Revoked
Sep 26, 2025
Publication Date
Jan 11, 2023
External Links
Slate, Register , Google Patents